Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Trends in Cancer|April 5, 2024
A big step for MYC-targeted therapiesDanielle F Atibalentja, Anja Deutzmann, Dean W FelsherBMC Bioinformatics|May 30, 2015
Discrimination of cell cycle phases in PCNA-immunolabeled cellsFelix Schönenberger, Anja Deutzmann, Elisa Ferrando-May, et al.Oncotarget|April 21, 2016
BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemiaYulin Li, Anja Deutzmann, Peter S Choi, et al.Scientific Reports|November 16, 2019
Mebendazole for Differentiation Therapy of Acute Myeloid Leukemia Identified by a Lineage Maturation IndexYulin Li, Daniel Thomas, Anja Deutzmann, et al.Journal of Biophotonics|February 20, 2013
Imaging of the DNA damage-induced dynamics of nuclear proteins via nonlinear photoperturbationMartin Tomas, Philipp Blumhardt, Anja Deutzmann, et al.Nature Reviews. Clinical Oncology|September 11, 2021
The MYC oncogene - the grand orchestrator of cancer growth and immune evasionRenumathy Dhanasekaran, Anja Deutzmann, Wadie D Mahauad-Fernandez, et al.Oncogene|October 7, 2022
MYC oncogene elicits tumorigenesis associated with embryonic, ribosomal biogenesis, and tissue-lineage dedifferentiation gene expression changesDelaney K Sullivan, Anja Deutzmann, Josiah Yarbrough, et al.Nature Communications|February 1, 2024
Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinomaAnja Deutzmann, Delaney K Sullivan, Renumathy Dhanasekaran, et al.Nature Communications|June 7, 2020
MYC functions as a switch for natural killer cell-mediated immune surveillance of lymphoid malignanciesSrividya Swaminathan, Aida S Hansen, Line D Heftdal, et al.Proceedings of the National Academy of Sciences of the United States of America|April 10, 2013
Intercellular trafficking of the nuclear oncoprotein DEKAnjan K Saha, Ferdinand Kappes, Amruta Mundade, et al.Pageof 2